AI Summary
✦ ClarthaPrice Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 38 analysts
Fundamentals
Fundamentals institutional score is 65 using growth durability 65.4.
Valuation
Valuation institutional score is 100 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 59 using mean target upside 22.7%; dispersion penalty 19.4; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 55 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 10 recent ticker-linked news items.
Signal Summary
Market intelligence remains Neutral. fundamentals and valuation provide support.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 18.7% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -1.91). Confidence: 90%.
Live forward EPS implies next-12-month EPS of ₹13.18. Applying the stock's normalized valuation corridor produces a fair range of ₹573.59 to ₹625.26, with base value near ₹604.83 (+46.6% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹13.18
Forward P/E
31.3x
Base Fair Value
₹604.83
Fair Range
₹573.59 - ₹625.26
Upside To Base
+46.6%
Estimate Source
Live forward EPS
Growth Estimate
+15.3%
5Y Average
46.43
Current
37.31
Overvalued
47.44
Undervalued
43.52
5Y Average
34.79
Current
27.96
Overvalued
36.30
Undervalued
33.33
5Y Average
6.72
Current
5.40
Overvalued
7.73
Undervalued
5.71
Peers & Comparison
Sector: Consumer Staples · Theme: FMCG - Personal Products
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
GODREJ CONSUMER PRODUCTS GODREJCPFMCG - Personal Products | +15.4% | 12.1% | 54.8x Fair | +11% vs avg | -13.8% |
DR. REDDY S LABORATORIES DRREDDYPharmaceuticals | -5.6% | 10.0% | 29.2x Undervalued | -41% vs avg | -1.3% |
CG POWER AND IND SOL LTD CGPOWERHeavy Electrical Equipments | +14.0% | 9.8% | 111.4x Premium | +126% vs avg | +33.5% |
HINDALCO INDUSTRIES LTD HINDALCOMetals - Aluminium | +32.1% | 5.5% | 14.3x Undervalued | -71% vs avg | +57.3% |
BAJAJ AUTO LIMITED BAJAJ-AUTOTwo Wheelers | +64.0% | 16.3% | 27.9x Undervalued | -43% vs avg | +41.6% |
EICHER MOTORS LTD EICHERMOTTrucks & Buses | +31.5% | 23.2% | 38.0x Undervalued | -23% vs avg | +41.4% |
BSE LIMITED BSEStock Exchanges & Ratings | +64.0% | 48.9% | 52.4x Fair | +6% vs avg | +44.4% |
APOLLO HOSPITALS ENTER. L APOLLOHOSPHospitals & Diagnostic Centres | +18.1% | 7.7% | 66.2x Premium | +34% vs avg | +12.1% |
DABUR INDIA LTD trades at a discount (37.3x vs peer avg 49.3x), suggesting potential undervaluation relative to the Fmcg - Personal Products cohort. Peers include GODREJ CONSUMER PRODUCTS, DR. REDDY S LABORATORIES, CG POWER AND IND SOL LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹2.69K CrJun 2026Latest net profit
₹452 CrJun 2026Latest EPS
₹2.55Jun 2026Net margin
20.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 2,347 | 2,334 | 2,414 | 2,039 | 2,514 | 2,144 | 2,448 | 1,965 | 2,470 | 2,235 | 2,547 | 2,132 | 2,687 |
| Expenses + | 1,885 | 1,826 | 1,883 | 1,703 | 2,017 | 1,740 | 1,926 | 1,680 | 1,984 | 1,811 | 1,992 | 1,815 | 2,152 |
| Operating Profit | 462 | 509 | 532 | 337 | 497 | 403 | 523 | 284 | 485 | 424 | 555 | 317 | 536 |
| OPM % | 20% | 22% | 22% | 16% | 20% | 19% | 21% | 14% | 20% | 19% | 22% | 15% | 20% |
| Other Income + | 99 | 102 | 102 | 114 | 110 | 118 | 105 | 119 | 116 | 106 | 93 | 147 | 131 |
| Interest | 15 | 18 | 24 | 23 | 19 | 29 | 28 | 23 | 17 | 20 | 22 | 23 | 22 |
| Depreciation | 51 | 51 | 52 | 54 | 60 | 64 | 64 | 63 | 63 | 64 | 66 | 67 | 67 |
| Profit before tax | 495 | 542 | 557 | 373 | 527 | 429 | 536 | 317 | 521 | 447 | 560 | 374 | 578 |
| Tax % | 24% | 22% | 23% | 24% | 23% | 23% | 22% | 21% | 22% | 22% | 21% | 21% | 22% |
| Net Profit + | 378 | 420 | 428 | 283 | 405 | 329 | 418 | 251 | 407 | 349 | 439 | 296 | 452 |
| EPS in Rs | 2.13 | 2.37 | 2.42 | 1.60 | 2.29 | 1.86 | 2.36 | 1.41 | 2.30 | 1.97 | 2.48 | 1.67 | 2.55 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).